3rd Circ. Urged To Revive Avandia Suit Against GSK
A Missouri woman who accused GlaxoSmithKline LLC of concealing dangerous side effects of its diabetes drug Avandia told the Third Circuit on Friday to revive a proposed class action, arguing that she...To view the full article, register now.
Already a subscriber? Click here to view full article